 | • レポートコード：QFJ1-4010 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、慢性肝疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法薬、標的療法、ワクチン、抗ウイルス薬、免疫グロブリン、コルチコステロイド、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・慢性肝疾患治療薬の市場動向 ・企業の競争状況、市場シェア ・慢性肝疾患治療薬の種類別市場規模と予測2016-2027（化学療法薬、標的療法、ワクチン、抗ウイルス薬、免疫グロブリン、コルチコステロイド、その他） ・慢性肝疾患治療薬の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局） ・慢性肝疾患治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・慢性肝疾患治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・慢性肝疾患治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・慢性肝疾患治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・慢性肝疾患治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Astellas Pharma、Bristol-Myers Squibb、Gilead Sciences、GlaxoSmithKline、F. Hoffmann-La Roche、Merck、Novartis、Sanofi、Pfizer、Takeda Pharmaceutical、Bausch Health、Theratechnologies、Alnylam Pharmaceuticals、Protagonist Therapeutics、Dicerna Pharmaceuticals、Endo International、Provectus Biopharmaceuticals、MAX BioPharma） ・結論 |
Market Analysis and Insights: Global Chronic Liver Diseases Therapeutics Market
The global Chronic Liver Diseases Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chronic Liver Diseases Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chronic Liver Diseases Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chronic Liver Diseases Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chronic Liver Diseases Therapeutics market.
Global Chronic Liver Diseases Therapeutics Scope and Market Size
Chronic Liver Diseases Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Liver Diseases Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chemotherapy Drugs
Targeted Therapy
Vaccines
Antiviral Drugs
Immunoglobulins
Corticosteroids
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Astellas Pharma
Bristol-Myers Squibb
Gilead Sciences
GlaxoSmithKline
F. Hoffmann-La Roche
Merck
Novartis
Sanofi
Pfizer
Takeda Pharmaceutical
Bausch Health
Theratechnologies
Alnylam Pharmaceuticals
Protagonist Therapeutics
Dicerna Pharmaceuticals
Endo International
Provectus Biopharmaceuticals
MAX BioPharma
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Liver Diseases Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy Drugs
1.2.3 Targeted Therapy
1.2.4 Vaccines
1.2.5 Antiviral Drugs
1.2.6 Immunoglobulins
1.2.7 Corticosteroids
1.2.8 Others
1.3 Market by Application
1.3.1 Global Chronic Liver Diseases Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Chronic Liver Diseases Therapeutics Market Perspective (2016-2027)
2.2 Chronic Liver Diseases Therapeutics Growth Trends by Regions
2.2.1 Chronic Liver Diseases Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chronic Liver Diseases Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Chronic Liver Diseases Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Chronic Liver Diseases Therapeutics Industry Dynamic
2.3.1 Chronic Liver Diseases Therapeutics Market Trends
2.3.2 Chronic Liver Diseases Therapeutics Market Drivers
2.3.3 Chronic Liver Diseases Therapeutics Market Challenges
2.3.4 Chronic Liver Diseases Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Liver Diseases Therapeutics Players by Revenue
3.1.1 Global Top Chronic Liver Diseases Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Chronic Liver Diseases Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Chronic Liver Diseases Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chronic Liver Diseases Therapeutics Revenue
3.4 Global Chronic Liver Diseases Therapeutics Market Concentration Ratio
3.4.1 Global Chronic Liver Diseases Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Liver Diseases Therapeutics Revenue in 2020
3.5 Chronic Liver Diseases Therapeutics Key Players Head office and Area Served
3.6 Key Players Chronic Liver Diseases Therapeutics Product Solution and Service
3.7 Date of Enter into Chronic Liver Diseases Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Liver Diseases Therapeutics Breakdown Data by Type
4.1 Global Chronic Liver Diseases Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Chronic Liver Diseases Therapeutics Forecasted Market Size by Type (2022-2027)
5 Chronic Liver Diseases Therapeutics Breakdown Data by Application
5.1 Global Chronic Liver Diseases Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Chronic Liver Diseases Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Chronic Liver Diseases Therapeutics Market Size (2016-2027)
6.2 North America Chronic Liver Diseases Therapeutics Market Size by Type
6.2.1 North America Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Chronic Liver Diseases Therapeutics Market Size by Type (2016-2027)
6.3 North America Chronic Liver Diseases Therapeutics Market Size by Application
6.3.1 North America Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Chronic Liver Diseases Therapeutics Market Size by Application (2016-2027)
6.4 North America Chronic Liver Diseases Therapeutics Market Size by Country
6.4.1 North America Chronic Liver Diseases Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Chronic Liver Diseases Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Chronic Liver Diseases Therapeutics Market Size (2016-2027)
7.2 Europe Chronic Liver Diseases Therapeutics Market Size by Type
7.2.1 Europe Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Chronic Liver Diseases Therapeutics Market Size by Type (2016-2027)
7.3 Europe Chronic Liver Diseases Therapeutics Market Size by Application
7.3.1 Europe Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Chronic Liver Diseases Therapeutics Market Size by Application (2016-2027)
7.4 Europe Chronic Liver Diseases Therapeutics Market Size by Country
7.4.1 Europe Chronic Liver Diseases Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Chronic Liver Diseases Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Type
8.2.1 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Application
8.3.1 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Region
8.4.1 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Chronic Liver Diseases Therapeutics Market Size (2016-2027)
9.2 Latin America Chronic Liver Diseases Therapeutics Market Size by Type
9.2.1 Latin America Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Chronic Liver Diseases Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Chronic Liver Diseases Therapeutics Market Size by Application
9.3.1 Latin America Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Chronic Liver Diseases Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Chronic Liver Diseases Therapeutics Market Size by Country
9.4.1 Latin America Chronic Liver Diseases Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Chronic Liver Diseases Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Type
10.2.1 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Application
10.3.1 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Country
10.4.1 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Details
11.1.2 Astellas Pharma Business Overview
11.1.3 Astellas Pharma Chronic Liver Diseases Therapeutics Introduction
11.1.4 Astellas Pharma Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
11.1.5 Astellas Pharma Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Chronic Liver Diseases Therapeutics Introduction
11.2.4 Bristol-Myers Squibb Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Chronic Liver Diseases Therapeutics Introduction
11.3.4 Gilead Sciences Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
11.3.5 Gilead Sciences Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Chronic Liver Diseases Therapeutics Introduction
11.4.4 GlaxoSmithKline Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
11.4.5 GlaxoSmithKline Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Chronic Liver Diseases Therapeutics Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Chronic Liver Diseases Therapeutics Introduction
11.6.4 Merck Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Chronic Liver Diseases Therapeutics Introduction
11.7.4 Novartis Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Chronic Liver Diseases Therapeutics Introduction
11.8.4 Sanofi Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Chronic Liver Diseases Therapeutics Introduction
11.9.4 Pfizer Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Takeda Pharmaceutical
11.10.1 Takeda Pharmaceutical Company Details
11.10.2 Takeda Pharmaceutical Business Overview
11.10.3 Takeda Pharmaceutical Chronic Liver Diseases Therapeutics Introduction
11.10.4 Takeda Pharmaceutical Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
11.10.5 Takeda Pharmaceutical Recent Development
11.11 Bausch Health
11.11.1 Bausch Health Company Details
11.11.2 Bausch Health Business Overview
11.11.3 Bausch Health Chronic Liver Diseases Therapeutics Introduction
11.11.4 Bausch Health Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
11.11.5 Bausch Health Recent Development
11.12 Theratechnologies
11.12.1 Theratechnologies Company Details
11.12.2 Theratechnologies Business Overview
11.12.3 Theratechnologies Chronic Liver Diseases Therapeutics Introduction
11.12.4 Theratechnologies Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
11.12.5 Theratechnologies Recent Development
11.13 Alnylam Pharmaceuticals
11.13.1 Alnylam Pharmaceuticals Company Details
11.13.2 Alnylam Pharmaceuticals Business Overview
11.13.3 Alnylam Pharmaceuticals Chronic Liver Diseases Therapeutics Introduction
11.13.4 Alnylam Pharmaceuticals Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
11.13.5 Alnylam Pharmaceuticals Recent Development
11.14 Protagonist Therapeutics
11.14.1 Protagonist Therapeutics Company Details
11.14.2 Protagonist Therapeutics Business Overview
11.14.3 Protagonist Therapeutics Chronic Liver Diseases Therapeutics Introduction
11.14.4 Protagonist Therapeutics Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
11.14.5 Protagonist Therapeutics Recent Development
11.15 Dicerna Pharmaceuticals
11.15.1 Dicerna Pharmaceuticals Company Details
11.15.2 Dicerna Pharmaceuticals Business Overview
11.15.3 Dicerna Pharmaceuticals Chronic Liver Diseases Therapeutics Introduction
11.15.4 Dicerna Pharmaceuticals Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
11.15.5 Dicerna Pharmaceuticals Recent Development
11.16 Endo International
11.16.1 Endo International Company Details
11.16.2 Endo International Business Overview
11.16.3 Endo International Chronic Liver Diseases Therapeutics Introduction
11.16.4 Endo International Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
11.16.5 Endo International Recent Development
11.17 Provectus Biopharmaceuticals
11.17.1 Provectus Biopharmaceuticals Company Details
11.17.2 Provectus Biopharmaceuticals Business Overview
11.17.3 Provectus Biopharmaceuticals Chronic Liver Diseases Therapeutics Introduction
11.17.4 Provectus Biopharmaceuticals Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
11.17.5 Provectus Biopharmaceuticals Recent Development
11.18 MAX BioPharma
11.18.1 MAX BioPharma Company Details
11.18.2 MAX BioPharma Business Overview
11.18.3 MAX BioPharma Chronic Liver Diseases Therapeutics Introduction
11.18.4 MAX BioPharma Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021)
11.18.5 MAX BioPharma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Chronic Liver Diseases Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy Drugs
Table 3. Key Players of Targeted Therapy
Table 4. Key Players of Vaccines
Table 5. Key Players of Antiviral Drugs
Table 6. Key Players of Immunoglobulins
Table 7. Key Players of Corticosteroids
Table 8. Key Players of Others
Table 9. Global Chronic Liver Diseases Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Chronic Liver Diseases Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Chronic Liver Diseases Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Chronic Liver Diseases Therapeutics Market Share by Regions (2016-2021)
Table 13. Global Chronic Liver Diseases Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Chronic Liver Diseases Therapeutics Market Share by Regions (2022-2027)
Table 15. Chronic Liver Diseases Therapeutics Market Trends
Table 16. Chronic Liver Diseases Therapeutics Market Drivers
Table 17. Chronic Liver Diseases Therapeutics Market Challenges
Table 18. Chronic Liver Diseases Therapeutics Market Restraints
Table 19. Global Chronic Liver Diseases Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Chronic Liver Diseases Therapeutics Market Share by Players (2016-2021)
Table 21. Global Top Chronic Liver Diseases Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Liver Diseases Therapeutics as of 2020)
Table 22. Ranking of Global Top Chronic Liver Diseases Therapeutics Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Chronic Liver Diseases Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Chronic Liver Diseases Therapeutics Product Solution and Service
Table 26. Date of Enter into Chronic Liver Diseases Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Chronic Liver Diseases Therapeutics Revenue Market Share by Type (2016-2021)
Table 30. Global Chronic Liver Diseases Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Chronic Liver Diseases Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Chronic Liver Diseases Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Chronic Liver Diseases Therapeutics Revenue Market Share by Application (2016-2021)
Table 34. Global Chronic Liver Diseases Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Chronic Liver Diseases Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Chronic Liver Diseases Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Chronic Liver Diseases Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Chronic Liver Diseases Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Chronic Liver Diseases Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Chronic Liver Diseases Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Chronic Liver Diseases Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 66. Astellas Pharma Company Details
Table 67. Astellas Pharma Business Overview
Table 68. Astellas Pharma Chronic Liver Diseases Therapeutics Product
Table 69. Astellas Pharma Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Astellas Pharma Recent Development
Table 71. Bristol-Myers Squibb Company Details
Table 72. Bristol-Myers Squibb Business Overview
Table 73. Bristol-Myers Squibb Chronic Liver Diseases Therapeutics Product
Table 74. Bristol-Myers Squibb Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Bristol-Myers Squibb Recent Development
Table 76. Gilead Sciences Company Details
Table 77. Gilead Sciences Business Overview
Table 78. Gilead Sciences Chronic Liver Diseases Therapeutics Product
Table 79. Gilead Sciences Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Gilead Sciences Recent Development
Table 81. GlaxoSmithKline Company Details
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Chronic Liver Diseases Therapeutics Product
Table 84. GlaxoSmithKline Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
Table 85. GlaxoSmithKline Recent Development
Table 86. F. Hoffmann-La Roche Company Details
Table 87. F. Hoffmann-La Roche Business Overview
Table 88. F. Hoffmann-La Roche Chronic Liver Diseases Therapeutics Product
Table 89. F. Hoffmann-La Roche Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
Table 90. F. Hoffmann-La Roche Recent Development
Table 91. Merck Company Details
Table 92. Merck Business Overview
Table 93. Merck Chronic Liver Diseases Therapeutics Product
Table 94. Merck Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Merck Recent Development
Table 96. Novartis Company Details
Table 97. Novartis Business Overview
Table 98. Novartis Chronic Liver Diseases Therapeutics Product
Table 99. Novartis Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Novartis Recent Development
Table 101. Sanofi Company Details
Table 102. Sanofi Business Overview
Table 103. Sanofi Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Sanofi Recent Development
Table 105. Pfizer Company Details
Table 106. Pfizer Business Overview
Table 107. Pfizer Chronic Liver Diseases Therapeutics Product
Table 108. Pfizer Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
Table 109. Pfizer Recent Development
Table 110. Takeda Pharmaceutical Company Details
Table 111. Takeda Pharmaceutical Business Overview
Table 112. Takeda Pharmaceutical Chronic Liver Diseases Therapeutics Product
Table 113. Takeda Pharmaceutical Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
Table 114. Takeda Pharmaceutical Recent Development
Table 115. Bausch Health Company Details
Table 116. Bausch Health Business Overview
Table 117. Bausch Health Chronic Liver Diseases Therapeutics Product
Table 118. Bausch Health Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
Table 119. Bausch Health Recent Development
Table 120. Theratechnologies Company Details
Table 121. Theratechnologies Business Overview
Table 122. Theratechnologies Chronic Liver Diseases Therapeutics Product
Table 123. Theratechnologies Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
Table 124. Theratechnologies Recent Development
Table 125. Alnylam Pharmaceuticals Company Details
Table 126. Alnylam Pharmaceuticals Business Overview
Table 127. Alnylam Pharmaceuticals Chronic Liver Diseases Therapeutics Product
Table 128. Alnylam Pharmaceuticals Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
Table 129. Alnylam Pharmaceuticals Recent Development
Table 130. Protagonist Therapeutics Company Details
Table 131. Protagonist Therapeutics Business Overview
Table 132. Protagonist Therapeutics Chronic Liver Diseases Therapeutics Product
Table 133. Protagonist Therapeutics Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
Table 134. Protagonist Therapeutics Recent Development
Table 135. Dicerna Pharmaceuticals Company Details
Table 136. Dicerna Pharmaceuticals Business Overview
Table 137. Dicerna Pharmaceuticals Chronic Liver Diseases Therapeutics Product
Table 138. Dicerna Pharmaceuticals Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
Table 139. Dicerna Pharmaceuticals Recent Development
Table 140. Endo International Company Details
Table 141. Endo International Business Overview
Table 142. Endo International Chronic Liver Diseases Therapeutics Product
Table 143. Endo International Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
Table 144. Endo International Recent Development
Table 145. Provectus Biopharmaceuticals Company Details
Table 146. Provectus Biopharmaceuticals Business Overview
Table 147. Provectus Biopharmaceuticals Chronic Liver Diseases Therapeutics Product
Table 148. Provectus Biopharmaceuticals Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
Table 149. Provectus Biopharmaceuticals Recent Development
Table 150. MAX BioPharma Company Details
Table 151. MAX BioPharma Business Overview
Table 152. MAX BioPharma Chronic Liver Diseases Therapeutics Product
Table 153. MAX BioPharma Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million)
Table 154. MAX BioPharma Recent Development
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Liver Diseases Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Drugs Features
Figure 3. Targeted Therapy Features
Figure 4. Vaccines Features
Figure 5. Antiviral Drugs Features
Figure 6. Immunoglobulins Features
Figure 7. Corticosteroids Features
Figure 8. Others Features
Figure 9. Global Chronic Liver Diseases Therapeutics Market Share by Application: 2020 VS 2027
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. Chronic Liver Diseases Therapeutics Report Years Considered
Figure 14. Global Chronic Liver Diseases Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Chronic Liver Diseases Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Chronic Liver Diseases Therapeutics Market Share by Regions: 2020 VS 2027
Figure 17. Global Chronic Liver Diseases Therapeutics Market Share by Regions (2022-2027)
Figure 18. Global Chronic Liver Diseases Therapeutics Market Share by Players in 2020
Figure 19. Global Top Chronic Liver Diseases Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Liver Diseases Therapeutics as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Chronic Liver Diseases Therapeutics Revenue in 2020
Figure 21. Global Chronic Liver Diseases Therapeutics Revenue Market Share by Type (2016-2021)
Figure 22. Global Chronic Liver Diseases Therapeutics Revenue Market Share by Type (2022-2027)
Figure 23. North America Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Chronic Liver Diseases Therapeutics Market Share by Type (2016-2027)
Figure 25. North America Chronic Liver Diseases Therapeutics Market Share by Application (2016-2027)
Figure 26. North America Chronic Liver Diseases Therapeutics Market Share by Country (2016-2027)
Figure 27. United States Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Chronic Liver Diseases Therapeutics Market Share by Type (2016-2027)
Figure 31. Europe Chronic Liver Diseases Therapeutics Market Share by Application (2016-2027)
Figure 32. Europe Chronic Liver Diseases Therapeutics Market Share by Country (2016-2027)
Figure 33. Germany Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Chronic Liver Diseases Therapeutics Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Chronic Liver Diseases Therapeutics Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Chronic Liver Diseases Therapeutics Market Share by Region (2016-2027)
Figure 43. China Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Chronic Liver Diseases Therapeutics Market Share by Type (2016-2027)
Figure 51. Latin America Chronic Liver Diseases Therapeutics Market Share by Application (2016-2027)
Figure 52. Latin America Chronic Liver Diseases Therapeutics Market Share by Country (2016-2027)
Figure 53. Mexico Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Chronic Liver Diseases Therapeutics Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Chronic Liver Diseases Therapeutics Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Chronic Liver Diseases Therapeutics Market Share by Country (2016-2027)
Figure 59. Turkey Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Astellas Pharma Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
Figure 64. Gilead Sciences Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
Figure 65. GlaxoSmithKline Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
Figure 66. F. Hoffmann-La Roche Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
Figure 67. Merck Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
Figure 68. Novartis Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
Figure 69. Sanofi Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
Figure 70. Pfizer Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
Figure 71. Takeda Pharmaceutical Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
Figure 72. Bausch Health Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
Figure 73. Theratechnologies Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
Figure 74. Alnylam Pharmaceuticals Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
Figure 75. Protagonist Therapeutics Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
Figure 76. Dicerna Pharmaceuticals Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
Figure 77. Endo International Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
Figure 78. Provectus Biopharmaceuticals Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
Figure 79. MAX BioPharma Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
世界の急性＆慢性肝不全市場規模・現状・予測（2021年-2027年） Acute-on-chronic liver failure is a syndrome that affects patients with chronic liver disease; is characterized by intense systemic inflammation, organ failure, and a poor prognosis; and frequently develops in close association with precipitating events. There is no specific treatment for patients w…- 世界のアルコール性肝疾患治療市場規模・現状・予測（2021年-2027年） Alcoholic liver diseases are the result of overconsumption of alcohol, which damages the liver, leading to liver cirrhosis, inflammation, and liver scarring. Market Analysis and Insights: Global Alcoholic Liver Diseases Treatment Market The global Alcoholic Liver Diseases Treatment market size is p…
- 世界の後期慢性腎臓病治療薬市場規模・現状・予測（2021年-2027年） Late stage chronic kidney disease therapeutics can be defined as the drugs which are used for the treatment of late-stage CKD - Induced, Hyperphosphatemia, Hyperparathyroidism and Hyperkalemia. Market Analysis and Insights: Global Late Stage Chronic Kidney Disease Drugs Market The global Late Stage …
- 世界の中枢神経系疾患治療薬市場規模・現状・予測（2021年-2027年） A drug used to treat neurological diseases that affect the functioning of the brain or spinal cord in the central nervous system Market Analysis and Insights: Global Drugs for Central Nervous System Diseases Market The global Drugs for Central Nervous System Diseases market size is projected to reac…
- 世界の移植治療薬市場規模・現状・予測（2021年-2027年） Transplantation is the transfer (engraftment) of human cells, tissues, or organs from a donor to a recipient, with the aim of restoring function(s) in the body. Market Analysis and Insights: Global Transplantation Therapeutics Drugs Market The global Transplantation Therapeutics Drugs market size is…